Cart
sales@molnova.com
Piperafizine A
CAS No. 130603-59-7
Piperafizine A( —— )
Catalog No. M28199 CAS No. 130603-59-7
Piperafizine A is isolated from Streptoverticillium aspergilloides and potentiates vincristine antitumor potency.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 945 | Get Quote |
|
| 5MG | 839 | Get Quote |
|
| 10MG | 1169 | Get Quote |
|
| 25MG | 1739 | Get Quote |
|
| 50MG | 2297 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePiperafizine A
-
NoteResearch use only, not for human use.
-
Brief DescriptionPiperafizine A is isolated from Streptoverticillium aspergilloides and potentiates vincristine antitumor potency.
-
DescriptionPiperafizine A is isolated from Streptoverticillium aspergilloides and potentiates vincristine antitumor potency.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number130603-59-7
-
Formula Weight304.349
-
Molecular FormulaC19H16N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCn1c(=O)\c(=C\c2ccccc2)[nH]c(=O)\c1=C\c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Satoh T, et al. Pharmacological analysis of local anaesthetic tolycaine-induced convulsions by modification of monoamines in rat brain. Pharmacol Toxicol. 1996 Dec;79(6):305-11.
molnova catalog
related products
-
CRF, bovine TFA (923...
CRF, bovine (TFA) is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM.CRF, bovine is a potent agonist of CRF receptor, and displaces [125I-Tyr]ovine CRF with a Ki of 3.52 nM. CRF shows pEC50s of 11.16, 8.53 and 8.70 for human CRF1, human CRF2 and rat CRF2α.
-
Peroxydehydrotumulos...
5alpha,8alpha-Peroxydehydrotumulosic acid exhibits inhibitory effects against the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells.
-
MAPKK2 (1-16) (human...
MAPKK2 (1-16) (human, mouse, rat)
